Sinil Pharmaceutical Co., Ltd. 012790.KQ Stock
Sinil Pharmaceutical Co., Ltd. Price Chart
Sinil Pharmaceutical Co., Ltd. 012790.KQ Financial and Trading Overview
Sinil Pharmaceutical Co., Ltd. stock price | 6930 KRW |
Previous Close | 7760 KRW |
Open | 7760 KRW |
Bid | 7790 KRW x 0 |
Ask | 7850 KRW x 0 |
Day's Range | 7760 - 7880 KRW |
52 Week Range | 7221.15 - 11153.85 KRW |
Volume | 54.81K KRW |
Avg. Volume | 41.38K KRW |
Market Cap | 58.39B KRW |
Beta (5Y Monthly) | 1.61666 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
012790.KQ Valuation Measures
Enterprise Value | 72.84B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.76856977 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.959 |
Enterprise Value/EBITDA | 4.233 |
Trading Information
Sinil Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 1.61666 |
52-Week Change | -5.054% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11153.85 KRW |
52 Week Low | 7221.15 KRW |
50-Day Moving Average | 8111.4 KRW |
200-Day Moving Average | 8181.68 KRW |
012790.KQ Share Statistics
Avg. Volume (3 month) | 41.38K KRW |
Avg. Daily Volume (10-Days) | 56.84K KRW |
Shares Outstanding | 7.51M |
Float | 6.95M |
Short Ratio | N/A |
% Held by Insiders | 39.51% |
% Held by Institutions | 0.68% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 1.04:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 14.56% |
Operating Margin (ttm) | 16.70% |
Gross Margin | 42.41% |
EBITDA Margin | 22.65% |
Management Effectiveness
Return on Assets (ttm) | 5.99% |
Return on Equity (ttm) | 9.58% |
Income Statement
Revenue (ttm) | 75.97B KRW |
Revenue Per Share (ttm) | 6762.08 KRW |
Quarterly Revenue Growth (yoy) | 23.59% |
Gross Profit (ttm) | 24.44B KRW |
EBITDA | 17.21B KRW |
Net Income Avi to Common (ttm) | 11.07B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 41.69% |
Balance Sheet
Total Cash (mrq) | 23.35B KRW |
Total Cash Per Share (mrq) | 2018.35 KRW |
Total Debt (mrq) | 173.27M KRW |
Total Debt/Equity (mrq) | 0.14 KRW |
Current Ratio (mrq) | 4.598 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 13.02B KRW |
Levered Free Cash Flow (ttm) | 4.1B KRW |
Profile of Sinil Pharmaceutical Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | 272, Sagajeong-ro |
ZIP | N/A |
Phone | 82 2 2211 6700 |
Website | https://www.sinilpharm.com |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
Sinil Pharmaceutical Co., Ltd. manufactures, markets, and sells pharmaceutical products in South Korea. It provides over the counter products, including products for headache, myalgia, pain, dyspepsia, heartburn, diarrhea, common cold, cough, sputum, allergy, anorexia, physical fatigue, liver disease, xerophthalmia, asthenopia, pregnant woman, athletes foot, skin wound, cutaneous disorder, herpes, virus infection, osteoarthritis, neuralgia, peripheral neuritis, peripheral nerve p, iron deficiency anemia, bronchitis, gastritis, colitis, hemorrhoid, venous insufficiency, ecchymosis, reti, hypertension, rhinitis, constipation, eczematous dermatitis, calcium deficiency, withdrawal, and alopecia, as well as interruption in blood circulation and climacteric. The company also offers products for respiratory diseases and liver, as well as circulator therapies; therapies for digestive system, diabetes mellitus, osteoporosis, and dysuria, as well as other therapies; and central nervous system depressants, anti-biotics, anti-viral agents, anti-protozoal agents, analgesics, febricides, muscle relaxants, anti-inflammatory agents, anti-histamines, adrenocortical hormones, vitamin preparations, and injection. In addition, the company provides drugs for animals; household medicines; cosmetics under the PHARMTREE brand name; and health functional foods and other products, as well as contract manufacturing organization and original development manufacturing services. It offers products in the form of tablets, hard capsules, plasters/patches and ointments, sold soft capsules, syrups, liquid injection, and powder injections. The company also exports its products. Sinil Pharmaceutical Co., Ltd. was founded in 1971 and is based in Seoul, South Korea.
Q&A For Sinil Pharmaceutical Co., Ltd. Stock
What is a current 012790.KQ stock price?
Sinil Pharmaceutical Co., Ltd. 012790.KQ stock price today per share is 6930 KRW.
How to purchase Sinil Pharmaceutical Co., Ltd. stock?
You can buy 012790.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sinil Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Sinil Pharmaceutical Co., Ltd. is 012790.KQ.
How many shares does Sinil Pharmaceutical Co., Ltd. have in circulation?
The max supply of Sinil Pharmaceutical Co., Ltd. shares is 11.56M.
What is Sinil Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Sinil Pharmaceutical Co., Ltd. PE Ratio is now.
What was Sinil Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Sinil Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.